Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany "Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified" (Thromb Haemost 2011; 105.5).

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Ohman, EM; Roe, MT

Published Date

  • May 2011

Published In

  • Thromb Haemost

Volume / Issue

  • 105 / 5

Start / End Page

  • 763 - 765

PubMed ID

  • 21394382

Pubmed Central ID

  • 21394382

Electronic International Standard Serial Number (EISSN)

  • 2567-689X

Digital Object Identifier (DOI)

  • 10.1160/TH11-03-0159

Language

  • eng

Conference Location

  • Germany